ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Merck initiates first clinical trial of TLR7 and 8 inhibitor as a potential treatment for severe symptoms of COVID-19 infection
July 06, 2020Merck, a leading science and technology company, announced the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug application (IND) for M5049 for the treatment of patients with Covid-19 pneumonia. -
EMD Serono Initiates Trial of TLR7, 8 Inhibitor as a Potential Treatment for Symptoms of Covid-19
July 03, 2020EMD Serono announced the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug application (IND) for M5049 for the treatment of patients with Covid-19 pneumonia.
Pharma Sources Insight January 2025
